Page last updated: 2024-10-26

ether and Idiopathic Pulmonary Fibrosis

ether has been researched along with Idiopathic Pulmonary Fibrosis in 2 studies

Ether: A mobile, very volatile, highly flammable liquid used as an inhalation anesthetic and as a solvent for waxes, fats, oils, perfumes, alkaloids, and gums. It is mildly irritating to skin and mucous membranes.
ether : An organooxygen compound with formula ROR, where R is not hydrogen.
diethyl ether : An ether in which the oxygen atom is linked to two ethyl groups.

Idiopathic Pulmonary Fibrosis: A common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Limper, AH1
Thangakunam, B1
Christopher, DJ1

Other Studies

2 other studies available for ether and Idiopathic Pulmonary Fibrosis

ArticleYear
Safety of IV Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis.
    Chest, 2017, Volume: 151, Issue:5

    Topics: Ether; Ethers; Humans; Idiopathic Pulmonary Fibrosis; Mesenchymal Stem Cell Transplantation; Mesench

2017
Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis: Well Done, but Subsequent Doses May Be Vital.
    Chest, 2018, Volume: 153, Issue:1

    Topics: Ether; Ethers; Humans; Idiopathic Pulmonary Fibrosis; Mesenchymal Stem Cell Transplantation; Mesench

2018